Med bibl SkaS

*00000000cam a2200000Mi 4500
*00178946
*00520181120083928.3
*006m     o  d
*007cr |n|||||||||
*008170804s2017    sz      o     000 0 eng d
*019  $a999606505$a1000023835$a1002359888$a1005756156$a1011796769$a1048142458
*020  $a9783319547411$q(electronic bk.)
*020  $a3319547410$q(electronic bk.)
*020  $z9783319547404
*020  $z3319547402
*0247 $a10.1007/978-3-319-54741-1$2doi
*029  $aAU@$b000060623878
*035  $a(OCoLC)999564918$z(OCoLC)999606505$z(OCoLC)1000023835$z(OCoLC)1002359888$z(OCoLC)1005756156$z(OCoLC)1011796769$z(OCoLC)1048142458
*035  $a(OCoLC)ocn999564918
*040  $aYDX$beng$erda$epn$cYDX$dN$dEBLCP$dNJR$dKOS$dGW5XE$dKOS$dN$dOCLCO$dUAB$dOCLCO$dYDX$dESU$dAZU$dUPM$dIOG$dCOO$dOH1$dOCLCQ$dMERER$dVT2$dOCLCQ$dOCLCO$dOCLCA$dMERUC$dOCLCO$dU3W$dCAUOI$dOCLCQ$dOCLCF$dKSU$dOCLCO$dOCLCQ$dAU@$dOCLCO
*049  $aMAIN
*050 4$aRC280.M37
*060 4$aQZ 360
*072 7$aHEA$x039000$2bisacsh
*072 7$aMED$x014000$2bisacsh
*072 7$aMED$x022000$2bisacsh
*072 7$aMED$x112000$2bisacsh
*072 7$aMED$x045000$2bisacsh
*072 7$aMMN$2bicssc
*08204$a616.07548
*24500$aPET/CT in melanoma /$cMichael S. Hofman, Rodney J. Hicks, editors.
*264 1$aCham, Switzerland :$bSpringer,$c2017.
*300  $a1 online resource.
*336  $atext$btxt$2rdacontent
*337  $acomputer$bc$2rdamedia
*338  $aonline resource$bcr$2rdacarrier
*347  $atext file$bPDF$2rda
*4901 $aClinicians' guides to radionuclide hybrid imaging, PET/CT
*5050 $aForeword; Preface; Acknowledgements; Contents; Contributors; 1: Melanoma; 1.1 Clinical Features; 1.2 Biopsy of the Lesion; 1.3 Classification; 1.3.1 Superficial Spreading Melanoma; 1.3.2 Nodular Melanoma; 1.3.3 Lentigo Maligna Melanoma (LMM); 1.3.4 Acrolentiginous Melanoma (ALM); 1.4 Classification/Staging; References; 2: Pathology of Melanoma; 2.1 Histopathology; 2.2 Sentinel Lymph Node Biopsy; 2.3 Synoptic Reporting of Melanoma; 2.4 Molecular Analysis; References; 3: Management of Melanoma; 3.1 Surgical Management of Primary Melanoma; 3.2 Sentinel Lymph Node Biopsy.
*5058 $a3.3 Management of Locoregional Recurrent Melanoma3.4 Radiotherapy; 3.5 Adjuvant Systemic Therapy of Melanoma; 3.6 Management of Metastatic Melanoma; 3.6.1 Targeted Systemic Therapy with MAPK Pathway Inhibition; 3.6.2 Immunotherapy; 3.6.3 Cytotoxic Chemotherapy; References; 4: Radiological Imaging in Melanoma; 4.1 Introduction; 4.2 Plain Radiographs; 4.3 Ultrasound; 4.4 Computerised Tomography (CT); 4.5 MRI; 4.6 Restaging Imaging; References; 5: Role of PET/CT in Melanoma; 5.1 Introduction; 5.2 Primary Diagnosis/Staging; 5.2.1 Sentinel Lymph Node Scintigraphy with SPECT/CT.
*5058 $a5.2.2 Sentinel Lymph Node Positive5.2.3 High-Risk Patients with Stage I or II Disease; 5.2.4 Stage III and IV Melanoma; 5.2.5 Limitations of FDG PET/CT; 5.3 Response Assessment; 5.3.1 Pitfalls; 5.3.2 Treatment Related Adverse Effects Mimicking Malignancy; 5.4 Surveillance; 5.5 Beyond FDG PET/CT; References; 6: PET/CT in Melanoma (Additional Teaching Cases); References; Index.
*520  $aThis pocket book provides up-to-date guidance on the use of PET/CT in patients with melanoma, which is of rapidly growing importance due to the emergence of immunotherapy. The role of PET/CT in diagnostic workup, staging, treatment selection, prognostication, and follow-up is clearly explained. Imaging features are described and illustrated with the aid of a series of teaching cases, and attention is drawn to normal variants, artifacts, and pitfalls. Readers will also find explanation of the relation of the clinical and pathological background to imaging and the value of PET/CT compared with conventional radiological imaging. The book is published within the Springer series Clinicians' Guides to Radionuclide Hybrid Imaging (compiled under the auspices of the British Nuclear Medicine Society) and will be an excellent asset for referring clinicians, nuclear medicine physicians, radiologists, radiographers, technologists, and nurses who routinely work in nuclear medicine and participate in multidisciplinary meetings.
*5880 $aPrint version record.
*590  $aSpringerLink$bSpringer Medicine eBooks 2017 English+International
*650 0$aMelanoma$xTomography.
*650 0$aTomography, Emission.
*650 0$aMedicine.
*650 0$aNuclear Medicine.
*650 0$aOncology.
*650 7$aHEALTH & FITNESS$xDiseases$xGeneral.$2bisacsh
*650 7$aMEDICAL$xClinical Medicine.$2bisacsh
*650 7$aMEDICAL$xDiseases.$2bisacsh
*650 7$aMEDICAL$xEvidence-Based Medicine.$2bisacsh
*650 7$aMEDICAL$xInternal Medicine.$2bisacsh
*650 7$aMedicine.$2fast$0(OCoLC)fst01014893
*650 7$aNuclear medicine.$2fast$0(OCoLC)fst01040348
*650 7$aOncology.$2fast$0(OCoLC)fst01045739
*650 7$aTomography, Emission.$2fast$0(OCoLC)fst01152464
*650 2$aMelanoma.$0https://id.nlm.nih.gov/mesh/D008545
*650 2$aTomography.$0https://id.nlm.nih.gov/mesh/D014054
*655 4$aElectronic books.
*7001 $aHofman, Michael S.
*7001 $aHicks, Rodney J.
*77608$iPrint version:$tPET/CT in melanoma.$dCham, Switzerland : Springer, 2017$z3319547402$z9783319547404$wIMP(OCoLC)(OCoLC)971355356
*830 0$aClinicians' guides to radionuclide hybrid imaging.$pPET/CT.
*85640$uhttp://link.springer.com/10.1007/978-3-319-54741-1
*938  $aEBL - Ebook Library$bEBLB$nEBL4932196
*938  $aEBSCOhost$bEBSC$n1566651
*938  $aYBP Library Services$bYANK$n14735195
*994  $a92$bSESKS
^